Global Transdermal Patch Market By Type (Fentanyl Transdermal Patch , Nicotine Transdermal Patch , Buprenorphine Transdermal Patch , and Others), By Application, By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028
- Published date: Nov 2021
- Report ID: 15591
- Number of Pages: 299
- Format:
- keyboard_arrow_up
The report on Transdermal Patch Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global transdermal patch market is segmented on the basis of type, application and geography.
The worldwide market for Transdermal Patch Market is expected to grow at a CAGR of roughly x.x% over the next ten years and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.
Transdermal Patch Market Scope:
By type, the market is segmented into Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patchand Oxybutynin Transdermal Patch. By application, the market is divided into The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time., Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped., Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.,
Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.and Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics.
It works by relaxing the bladder muscles.. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyaoand Rfl Pharmaceutical.
Key Market Segments:
Type
- Fentanyl Transdermal Patch
- Nicotine Transdermal Patch
- Buprenorphine Transdermal Patch
- Clonidine Transdermal Patch
- Oxybutynin Transdermal Patch
Application
- The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
- Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.
- Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
- Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.
- Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.
Key Market Players included in the report:
- Hisamitsu Pharmaceutical
- Novartis
- Johnson & Johnson
- Teikoku Pharma
- Mylan
- Actavis
- Mundipharma
- Henan Lingrui Pharmaceutical
- Changzhou Siyao
- Rfl Pharmaceutical
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Transdermal Patch Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Transdermal Patch Market, high-growth regions, and market drivers, restraints and also market chances.
The analysis covers Transdermal Patch Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Transdermal Patch Market across sections such as also application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Transdermal Patch Market together side their company profiles, SWOT analysis, latest advancements and business plans.
The analysis objectives of the report are:
- To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
- To know the Transdermal Patch Market by pinpointing its many subsegments.
- To profile the important players and analyze their growth plans.
- To endeavor the amount and value of Transdermal Patch sub-markets, depending on key regions (various vital states).
- To analyze Transdermal Patch Market concerning growth trends, prospects and also their participation in the entire sector.
- To examine and study the Transdermal Patch Market size (volume & value) from the company, essential regions/countries, products and application, background information from 2012 to 2018 and also prediction to 2028.
- Primary worldwide Transdermal Patch Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
- To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.
For the Transdermal Patch Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
- Hisamitsu Pharmaceutical
- Novartis AG Company Profile
- Johnson & Johnson
- Teikoku Pharma
- Mylan
- Actavis
- Mundipharma
- Henan Lingrui Pharmaceutical
- Changzhou Siyao
- Rfl Pharmaceutical
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |